Showing results (141-150 of 171) with videos related to
Sort By:
Pageof 18
Blood|April 1, 1992
Retroviral expression of recombinant p47phox protein by Epstein-Barr virus-transformed B lymphocytes from a patient with autosomal chronic granulomatous diseaseC S Cobbs, H L Malech, T L Leto, et al.Gene Therapy|August 6, 1999
Adeno-retroviral chimeric viruses as in vivo transducing agentsN J Caplen, J N Higginbotham, J R Scheel, et al.The Journal of Experimental Medicine|September 1, 1982
Cooperative interaction of factor B and other complement components with mononuclear cells in the antibody-independent lysis of xenogeneic erythrocytesR E Hall, R M Blaese, A E Davis, et al.Gene Therapy|September 26, 2001
AV.TK-mediated killing of subcutaneous tumors in situ results in effective immunization against established secondary intracranial tumor depositsT Okada, M Shah, J N Higginbotham, et al.Cancer Gene Therapy|June 1, 1995
Toxicity studies and distribution dynamics of retroviral vectors following intrathecal administration of retroviral vector-producer cellsE M Oshiro, J J Viola, E H Oldfield, et al.Cancer Research|April 15, 1994
Intrathecal gene therapy for malignant leptomeningeal neoplasiaZ Ram, S Walbridge, E M Oshiro, et al.The New England Journal of Medicine|June 26, 1980
X-linked hypogammaglobulinemia and isolated growth hormone deficiencyT A Fleisher, R M White, S Broder, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1989
Establishment and characterization of adenosine deaminase-deficient human T cell linesD B Kohn, H Mitsuya, M Ballow, et al.Human Gene Therapy|October 1, 1993
A study of the safety and survival of the adoptive transfer of genetically marked syngeneic lymphocytes in HIV-infected identical twinsR Walker, R M Blaese, C S Carter, et al.Human Gene Therapy|January 1, 1994
Improved methods of retroviral vector transduction and production for gene therapyH Kotani, P B Newton, S Zhang, et al.Pageof 18